The Economic Impact of OMRF

Adding New Dollars and Jobs to Oklahoma

OMRF Technology and Spin-off Companies

What the Future Holds

The work of OMRF scientists also has yielded more than 500 domestic and international patents. These patents speed the movement of discoveries from bench to bedside, ensuring that patients receive the treatments they need in the shortest possible time. And every one of these patented discoveries represents a potential revenue source. With each patent that gives birth to a new drug, OMRF—and Oklahoma’s economy—can reap millions of dollars.

Each patented discovery also represents a potential new business venture, and OMRF has spun off numerous biotech start-up companies. These companies, in turn, fuel widespread private-sector growth, creating high-quality, high-paying jobs, many right here in Oklahoma.

OMRF Spinoff Companies

• Alexion Pharmaceuticals, Inc.
• Bridge-Blood Technology (now part of Bioenvision, Inc.)
• Centaur, Inc. (now a part of Renovis, Inc.)
• HealthAide, Inc.
• InterGenetics, Inc.
• J.K. Autoimmunity
• Molecular Image, Inc.
• Onconos, INC.
• ProteomTech, Inc.
• Riley Genomics, Inc.
• Zapaq, Inc. (now part of Athenagen, Inc.)